Screener
STERIS STE EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerBasicShare.
The source filing: STERIS’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054830
| Line item | Three Months Ended June 30, 2026 | 2025 |
|---|---|---|
| Income tax expense | 72.5 | 53.9 |
| Net income | 201.0 | 178.0 |
| Less: Net income attributable to noncontrolling interests | 0.9 | 0.6 |
| Net income attributable to shareholders | $200.1 | $177.4 |
| Net income per share attributable to shareholders: | ||
| Basic | $2.05 | $1.80 |
| Diluted | $2.04 | $1.79 |
| Cash dividends declared per share ordinary outstanding | $0.63 | $0.57 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is STERIS's EPS (basic)?
- STERIS (STE) reported EPS (basic) of $2.05 in Q2 2026.
- How has STERIS's EPS (basic) changed year-over-year?
- STERIS's EPS (basic) increased by 13.9% year-over-year, from $1.80 to $2.05.
- What is the long-term trend for STERIS's EPS (basic)?
- Over 4 years (2022 to 2026), STERIS's EPS (basic) has grown at a 34.7% compound annual growth rate (CAGR), from $2.42 to $7.96.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about STERIS's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude